Searched for
CORONA INDIA GROWTH
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCLMarkets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying....- PM Modi pushes deeper India-Netherlands collaboration in AI, chips and clean energy during The Hague visitPrime Minister Narendra Modi urged stronger India-Netherlands ties in resilient supply chains and green hydrogen. He highlighted India's di...
- PM Modi pushes work-from-home revival, lower foreign travel & less gold purchases as West Asia conflict heightens concernsPrime Minister Narendra Modi called for a return to work-from-home and urged citizens to delay foreign travel for a year. This is to addres...
- Corona Remedies shares make strong start, list at 38% premium over IPO priceCorona Remedies Share Price: Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1...
- Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma playCorona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expecta...
- Corona Remedies IPO Day 1: Registers over 30% subscription, strong GMP, and key detailsCorona Remedies’ IPO opened with decent subscription demand, led by strong retail demand and a robust Rs 290 grey-market premium. The Rs 65...
- Is Corona Remedies’ IPO a compelling bet for long-term wealth creation?Corona Remedies is set to raise ₹655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growt...
- CORONA remedies buys Sanofi India's ortho brand MyorilAhmedabad-based pharmaceutical company CORONA Remedies has acquired the muscle relaxant brand Myoril from Sanofi India for Rs234 crore. The...
- Insurance to cover M&A risks is on the rise here: Aon Asia PacificAccording to her, most M&As, particularly those with an international component, seek to protect some of it. "India is a growing and unders...
- Covid-related posts on Twitter at an all-time high from India; daily tweets up 7X in April-MaySocial media emerged as a lifeline for many during the second wave of the pandemic.
- Creador sells Corona Remedies stake to ChrysCapitalCreador III acquired a minority stake in Corona Remedies in July 2016, for Rs 118 crore. With this exit, Creador III has realised 15 per ce...
- 1.28 cr people covered under corona insurance policies: Irdai chief KhuntiaHopeful for an economic revival with the falling cases of coronavirus in the country and that people are getting vaccinated, he said huge o...
- New products likely to lift Colgate fortunesIn FY20, its revenue growth was muted followed by a mere 1% growth in the first half of FY21. However, the trend may reverse since analysts...
- November starts on a positive note as pick up in business activity continues: NomuraNomura India Business Resumption Index (NIBRI) rose to yet another post-lockdown high of 85.8 for the week ended November 8, from 84.7 post...
- India's October factory growth at decade high as demand bounces backAsia's third-largest economy is healing after shrinking a record 23.9% in the April-June quarter. The Nikkei Manufacturing Purchasing Manag...
- FM Nirmala Sitharaman sees GDP growth in negative zone or near zero in current fiscalThere was a "very firm lockdown" imposed beginning March 25 as the government put lives before livelihood. The lockdown also gave time to d...
- Covid-19 insurance: IRDAI may extend Corona Kavach and Corona Rakshak policiesThe popularity of the two standardised policies has been growing substantially, according to Alamelu. After an initial spurt in the number ...
- Corona Kavach health insurance policy evokes good response: InsurersCorona Kavach, which was launched on July 10 and is being offered by both general and health insurers, is a standard health insurance polic...
- Creador to invest Rs 118 crore in Corona RemediesCydista Ltd, an affiliate of Creador III L.P., has committed Rs 118 crore ($17.6 million) for a minority stake in Corona Remedies Private L...
- Corona inks agreement with Kitozyme for a fat binder anti-obesity drugBelgium life science company, Kitozyme entered into in-licensing agreement with Corona Remedies for fat binder anti-obesity drug.
Load More
